Evaluation of the Superficial Cervical Plexus Block in Oncological Throat and Neck Surgery (NCT07110857) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of the Superficial Cervical Plexus Block in Oncological Throat and Neck Surgery
France346 participantsStarted 2025-09
Plain-language summary
This national, prospective, multicenter, randomized study aims to reduce the amount of intravenous morphine (titration + PCA morphine) during the first 24 postoperative hours via a locoregional anesthesia technique in patients undergoing throat and neck cancer surgery.
Who can participate
Age range18 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patient undergoing ENT cancer surgery with cervicotomy
* Adult patient having received oral information from a doctor and signed written consent
* Affiliation to a social security scheme, Universal Medical Coverage (CMU)
Exclusion Criteria:
* Patient refusal
* Altered mental faculties or patient unable to give consent
* Allergy to local anesthetics
* Severe respiratory pathology (altered respiratory function tests with 50% \< FEV1 \< 80%, FEV1/FVC \< 70%, COPD stage 2 or more)
* Preoperative SpO2 less than 92% in ambient air
* Left heart failure NYHA 3 or more, impaired LVEF \< 30% or less
* Lower respiratory infection in the month preceding surgery
* History of ENT cancer surgery with cervical lymph node dissection
* Pregnant or breastfeeding woman
* Patient under AME
* Patient under guardianship or reinforced curatorship
* Participation in other interventional research